Showing results (171-180 of 2,066) with videos related to

Sort By:
Pageof 207
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
Novel red fluorescence protein based microplate assay for drug screening against dormant Mycobacterium tuberculosis by using paraffinAmar Yeware, Dhiman Sarkar
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
Normalised quantitative polymerase chain reaction for diagnosis of tuberculosis-associated uveitisManas Ranjan Barik, Soveeta Rath, Rohit Modi, et al.
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
RDRioMycobacterium tuberculosis lineage in the Brazil/Paraguay/Argentina triple borderAryadne Larissa de Almeida, Regiane Bertin de Lima Scodro, Hayalla Corrêa de Carvalho, et al.
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung diseaseChin-Chung Shu, Jann-Yuan Wang, Ming-Fang Wu, et al.
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
Evaluation of pyrosequencing for extensive drug resistance-defining anti-tuberculosis drugs for use in public healthcareRemya Nambiar, Daksha Shah, Kanchan Ajbani, et al.
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
On sunspots, click science and molecular iconographyIgor Mokrousov
Tuberculosis (Edinburgh, Scotland)|May 22, 2018
Tag Array gene chip rapid diagnosis anti-tuberculosis drug resistance in pulmonary tuberculosis -a feasibility studyWenjie Wu, Peng Cheng, Jingtong Lyu, et al.
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residentsSushil Pandey, Evelyn Lavu, Jacob Congdon, et al.
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in TaiwanHsin-Yun Sun, Yi-Wen Huang, Wei-Chang Huang, et al.
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infectionLinda Petrone, Valentina Vanini, Teresa Chiacchio, et al.
Pageof 207